JPL Wealth Management, LLC
Position in NBIX — Neurocrine Biosciences Inc
CIK 2010710
GREENWOOD VILLAGE, CO
Position in NBIX
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$9,438
+$1,402 QoQ
Shares Held
56
-8.2% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#685
of 768 holders
Holding Since
Mar 2026
2 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in NBIX Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026JPL Wealth Management, LLC holds $53,794 across 22 Drug Manufacturers - Specialty & Generic names. NBIX ranks #2 (17.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VTRS |
Viatris Inc
|
1,572 | $24,963 | |
| 2 | NBIX |
Neurocrine Biosciences Inc
This page
|
56 | $9,438 | |
| 3 | UTHR |
UNITED THERAPEUTICS Corp
|
12 | $6,501 | |
| 4 | LNTH |
Lantheus Holdings, Inc.
|
20 | $2,218 | |
| 5 | SUPN |
Supernus Pharmaceuticals, Inc.
|
40 | $1,860 | |
| 6 | ELAN |
Elanco Animal Health Inc
|
65 | $1,599 | |
| 7 | AMRX |
Amneal Pharmaceuticals, Inc.
|
88 | $1,523 | |
| 8 | RDY |
Dr Reddys Laboratories Ltd
|
90 | $1,304 |
All Filings in NBIX
Export CSV
2 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $9,438 | 56 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $8,036 | 61 | Shares | Sole | 2026-05-08 | |
| No filing history on record for this holder in this stock. | ||||||